| RS1555538571 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS1555538740 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1555538825 |
ASPA
|
Health Risk |
Pathogenic |
Spongy degeneration of central nervous system, Spongy degeneration of central nervous system |
| RS1555539013 |
CARMIL2
|
Health Risk |
Likely pathogenic |
— |
| RS1555539105 |
ASPA
|
Health Risk |
Likely pathogenic |
Spongy degeneration of central nervous system, Spongy degeneration of central nervous system |
| RS1555539157 |
AARS1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 29 |
| RS1555539322 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS1555539335 |
AARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1555539827 |
MYO15A
|
Health Risk |
Pathogenic/Likely pathogenic |
Rare genetic deafness, Rare genetic deafness |
| RS1555539857 |
ASPA
|
Health Risk |
Likely pathogenic |
Spongy degeneration of central nervous system, Spongy degeneration of central nervous system |
| RS1555539897 |
ASPA
|
Health Risk |
Likely pathogenic |
Spongy degeneration of central nervous system, Spongy degeneration of central nervous system |
| RS1555539903 |
ASPA
|
Health Risk |
Likely pathogenic |
Canavan Disease, Familial Form |
| RS1555540048 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS1555540076 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1555540674 |
ASPA
|
Health Risk |
Likely pathogenic |
Spongy degeneration of central nervous system, Spongy degeneration of central nervous system |
| RS1555540679 |
ASPA
|
Health Risk |
Likely pathogenic |
— |
| RS1555540896 |
AARS1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1555541278 |
ASPA
|
Health Risk |
Likely pathogenic |
Spongy degeneration of central nervous system, Spongy degeneration of central nervous system |
| RS1555541291 |
ASPA
|
Health Risk |
Likely pathogenic |
Spongy degeneration of central nervous system, Spongy degeneration of central nervous system |
| RS1555541304 |
ASPA
|
Health Risk |
Pathogenic |
Spongy degeneration of central nervous system, Spongy degeneration of central nervous system |
| RS1555541483 |
SLC13A5
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 25 |
| RS1555541486 |
SLC13A5
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 25 |
| RS1555542415 |
AARS1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2N, Charcot-Marie-Tooth disease axonal type 2N |
| RS1555542860 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS1555542889 |
FA2H
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1555543296 |
MYO15A
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555543432 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS1555543836 |
MYO15A
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS1555544187 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS1555545033 |
THRA
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Congenital nongoitrous hypothyroidism 6 |
| RS1555545225 |
MYO15A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555545421 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1555545517 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1555545553 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS1555545592 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1555546096 |
CHRNE
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4A |
| RS1555546224 |
CHRNE
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4A |
| RS1555546315 |
CHRNE
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4A |
| RS1555546465 |
CHRNE
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4B |
| RS1555546699 |
MYO15A
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS1555546717 |
MYO15A
|
Health Risk |
Likely pathogenic |
— |
| RS1555546765 |
CHRNE
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4C |
| RS1555546796 |
ARHGEF15
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1555546858 |
CHRNE
|
Health Risk |
Likely pathogenic |
— |
| RS1555547003 |
CHRNE
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4A |
| RS1555547008 |
CRYBA1
|
Health Risk |
Likely pathogenic |
Cataract 10 multiple types, Cataract 10 multiple types |
| RS1555547112 |
MYO15A
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS1555547215 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital sensorineural hearing impairment, Hearing loss |
| RS1555547474 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1555547524 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS1555547935 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1555547955 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1555548428 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS1555548512 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1555548632 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1555548670 |
KRT10
|
Health Risk |
Pathogenic |
— |
| RS1555548680 |
STAT5B
|
Health Risk |
Pathogenic |
Growth hormone insensitivity with immune dysregulation 1, autosomal recessive |
| RS1555549041 |
GP1BA
|
Health Risk |
Likely pathogenic |
Bernard Soulier syndrome, Bernard Soulier syndrome |
| RS1555549451 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1555549535 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1555549674 |
STAT5B
|
Health Risk |
Pathogenic |
Growth hormone insensitivity with immune dysregulation 1, autosomal recessive |
| RS1555549754 |
PEX12
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder type 3B, Peroxisome biogenesis disorder 3A (Zellweger) |
| RS1555549755 |
HSF4
|
Health Risk |
Pathogenic |
Cataract 5 multiple types, Cataract 5 multiple types |
| RS1555549769 |
PEX12
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder type 3B, Peroxisome biogenesis disorder 3A (Zellweger) |
| RS1555549841 |
PEX12
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder type 3B, Peroxisome biogenesis disorder 3A (Zellweger) |
| RS1555549855 |
PEX12
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder type 3B |
| RS1555549869 |
PEX12
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder 3A (Zellweger) |
| RS1555549876 |
PEX12
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder type 3B |
| RS1555549902 |
PEX12
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder type 3B |
| RS1555549909 |
PEX12
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder type 3B |
| RS1555549923 |
PEX12
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder type 3B |
| RS1555550025 |
PRPF8
|
Health Risk |
Likely pathogenic |
— |
| RS1555550045 |
PRPF8
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1555550180 |
PRPF8
|
Health Risk |
Pathogenic |
— |
| RS1555550617 |
PRPF8
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 13, Retinitis pigmentosa |
| RS1555550717 |
TNFRSF13B
|
Health Risk |
Pathogenic/Likely pathogenic |
Immunodeficiency, common variable |
| RS1555550982 |
PRPF8
|
Health Risk |
Pathogenic |
— |
| RS1555551460 |
PRPF8
|
Health Risk |
Likely pathogenic |
— |
| RS1555551738 |
PIEZO1
|
Health Risk |
Likely pathogenic |
— |
| RS1555552004 |
CHRNB1
|
Health Risk |
Pathogenic |
— |
| RS1555552006 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1555552070 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1555552506 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1555554139 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Pulmonic stenosis, Familial thoracic aortic aneurysm and aortic dissection |
| RS1555554788 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS1555556099 |
PITPNM3
|
Health Risk |
Pathogenic |
Cerebral arteriovenous malformation, Cerebral arteriovenous malformation |
| RS1555556175 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS1555558034 |
CTNS
|
Health Risk |
Likely pathogenic |
Nephropathic cystinosis, Nephropathic cystinosis |
| RS1555558078 |
CTNS
|
Health Risk |
Likely pathogenic |
Nephropathic cystinosis, Nephropathic cystinosis |
| RS1555558099 |
CTNS
|
Health Risk |
Pathogenic |
Nephropathic cystinosis, Ocular cystinosis |
| RS1555558116 |
CTNS
|
Health Risk |
Likely pathogenic |
Nephropathic cystinosis, Inborn genetic diseases |
| RS1555558169 |
SCAPER
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Intellectual developmental disorder and retinitis pigmentosa |
| RS1555558553 |
CACNA1G
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia 42, early-onset |
| RS1555558690 |
HOXB13
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555558920 |
G6PC1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA, Glycogen storage disease due to glucose-6-phosphatase deficiency type IA |
| RS1555559279 |
G6PC1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA, Glycogen storage disease due to glucose-6-phosphatase deficiency type IA |
| RS1555559733 |
G6PC1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA, Glycogen storage disease due to glucose-6-phosphatase deficiency type IA |
| RS1555559741 |
G6PC1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA, Glycogen storage disease due to glucose-6-phosphatase deficiency type IA |
| RS1555559991 |
G6PC1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA, Glycogen storage disease due to glucose-6-phosphatase deficiency type IA |
| RS1555560128 |
G6PC1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA, Glycogen storage disease due to glucose-6-phosphatase deficiency type IA |